WHO Expert Committee on Drug Dependence [meeting held in Geneva from 22 to 28 April 1986] : twenty-third report.
Material type:
TextSeries: World Health Organization technical report series ; no. 741Publication details: Geneva : World Health Organization, 1987.Description: 64 pISBN: - 9241207418
- WM 270
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | HQ SERIAL (Browse shelf(Opens below)) | 1 | Available | 00000578 | ||
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | WM 270 87WH (Browse shelf(Opens below)) | 2 | Withdrawn | 00000574 | ||
|
Books
|
WHO HQ ONLINE-IRIS | WM 270 87WH (Browse shelf(Opens below)) | 3 | Available | O9241207418 | ||
|
Books
|
WHO HQ ONLINE-IRIS | HQ SERIAL RUS (Browse shelf(Opens below)) | 1 | Available | O9241207418RUS |
Russian version of nos. 728-749 bound together (barcode no. 00073792).
Assesses data on 31 barbiturates in order to determine which of these substances should be recommended for international control. Barbiturates are classified in three main groups: ultra-short-acting barbiturates used as intravenous anaesthetics or for the induction of anaesthesia, the intermediate-acting barbiturates used mainly as hypnotics and daytime sedatives, and other longer-acting substances used in the management of epilepsy. Five of the 31 substances are recommended for placement in Schedule III or IV. A concluding section, devoted to recommendations for improving review procedures, discusses the problems caused by the difficulty of obtaining phenobarbital in many developing countries, especially in view of the effectiveness of this Schedule IV substance in the treatment of epilepsy.
eng fre rus spa.
WHODOC
WHO monograph
4
There are no comments on this title.